Article
Virological response, HIV-1 drug resistance mutations and genetic diversity among patients on first-line antiretroviral therapy in N'Djamena, Chad: findings from a cross-sectional study.
BMC research notes - 10 Nov 2017
Adawaye Chatté, Fokam Joseph, Kamangu Erick, Alio Hamit Mahamat, Chahad Aoudalkarim Moussa, Susin Fabrice, Moussa Ali Mahamat, Bertin Tchombou Hig-Zounet, Tidjani Abdelsalam, Vaira Dolores, Moutschen Michel
Abstract excerpt
BACKGROUND: The national antiretroviral therapy in the Republic of Chad provides free of charge antiretroviral regimens and therapeutic monitoring for patients receiving antiretroviral therapy nationwide. For a successful programmatic uptake, these efforts merit to be supported by thorough assessments of antiretroviral therapy response and HIV-1 drug resistance surveillance, especially with risks of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.